A mechanistic study in the B16 melanoma model demonstrated that IFNγ-driven resistance mechanisms may be due to signaling effects on tumor cells, and disruption of tumor-specific IFNγ signaling can rescue ICI sensitivity (49). The gene discussed is IFNG; the disease is melanoma.